Lithuanian Lung Cancer Implementation Guide
0.0.1 - ci-build Lithuania vėliava

Lithuanian Lung Cancer Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-lung/ and changes regularly. See the Directory of published versions

Table of Contents

Dabartiniam puslapiui nėra vertimo puslapio, todėl jis pateiktas numatytąja kalba

.. 0 Table of Contents
... 1 Home
... 2 Workflow
... 3 Profiles
... 4 Terminology
... 5 Examples
... 6 Questionnaires
... 7 Artifacts Summary
.... 7.1 Questionnaire: LDCT ESPBI Form (LT Lung)
.... 7.2 Questionnaire: Pre-LDCT Questionnaire (LT Lung)
.... 7.3 Adrenal Lesion (LT Lung)
.... 7.4 Incidental Finding (LT Lung)
.... 7.5 Kidney Lesion (LT Lung)
.... 7.6 Lung Composition (LT Lung)
.... 7.7 Lung LDCT Report (LT Lung)
.... 7.8 Lung Screening Recommendation (LT Lung)
.... 7.9 LUNG-RADS Assessment (LT Lung)
.... 7.10 Mediastinal Mass (LT Lung)
.... 7.11 Pulmonary Nodule (LT Lung)
.... 7.12 Adrenal Laterality
.... 7.13 Consolidation Interpretation
.... 7.14 Coronary Calcification Visual Score
.... 7.15 Finding Density
.... 7.16 Finding Multiplicity
.... 7.17 Finding Quantity
.... 7.18 Incidental Finding
.... 7.19 Kidney Laterality
.... 7.20 Kidney Lesion Density
.... 7.21 Lung Lobe
.... 7.22 Lung Screening Recommendation Value Set
.... 7.23 LUNG-RADS Assessment Category
.... 7.24 LUNG-RADS Assessment Modifier Codes
.... 7.25 Lymph Node Location
.... 7.26 Pulmonary Nodule Morphology Features
.... 7.27 Pulmonary Nodule Type
.... 7.28 Lung questionnaire answer options
.... 7.29 Lung Screening Recommendation Codes
.... 7.30 LUNG-RADS Assessment Categories
.... 7.31 LUNG-RADS Assessment Modifier
.... 7.32 Pulmonary Nodule Observation Component Codes
.... 7.33 Pulmonary Nodule Type Local Codes
.... 7.34 SNOMED CT Extension Codes
.... 7.35 Composition: LDCT Screening Report (example)
.... 7.36 DiagnosticReport: LDCT Screening Report (example)
.... 7.37 ImagingStudy: LDCT Screening (example)
.... 7.38 Observation: Bilateral Pleural Effusion (example)
.... 7.39 Observation: Coronary Artery Calcification, Moderate (example)
.... 7.40 Observation: Ground Glass Nodule – Right Middle Lobe, 9 mm (example)
.... 7.41 Observation: Lung Consolidation, Likely Inflammatory (example)
.... 7.42 Observation: Lung screening recommendation - 3 month (example)
.... 7.43 Observation: Lung screening recommendation - pulmonologist consultation (example)
.... 7.44 Observation: LUNG-RADS 4A with S modifier (example)
.... 7.45 Observation: LUNG-RADS Category 4A (example)
.... 7.46 Observation: Mediastinal Lymphadenopathy, Multiple, Bilateral (example)
.... 7.47 Observation: Mediastinal Mass with Abnormal Density (example)
.... 7.48 Observation: Part-Solid Nodule – Left Upper Lobe, 18 mm (example)
.... 7.49 Observation: Pulmonary Emphysema, Severe (example)
.... 7.50 Observation: Right Adrenal Lesion, 18mm, 12 HV (example)
.... 7.51 Observation: Solid Nodule – Right Upper Lobe, 11 mm (example)
.... 7.52 Organization: Santaros Klinikos (example)
.... 7.53 Patient: Male (example)
.... 7.54 Practitioner: Radiologist (example)
.... 7.55 PractitionerRole: Radiologist (example)
.... 7.56 Procedure: LDCT Screening (example)
.... 7.57 QuestionnaireResponse: LDCT ESPBI (example)
.... 7.58 QuestionnaireResponse: Pre-LDCT Questionnaire (example)